Sort
46,585 grants matching “heart failure”
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$1,992,402Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
SPECIALIZED CENTER OF RESEARCH IN SUDDEN CARDIAC DEATH
$1,992,146Johns Hopkins University · P50 · FY2004 · HL
Molecular Basis of Dilated &Hypertrophic Cardiomyopathy
$1,990,786University Of Vermont &St Agric College · P01 · FY2005 · HL
Biology and Novel Therapeutics of Cardiovascular Peptides
$1,988,914John C Burnett · Mayo Clinic Rochester · P01 · FY2011 · HL
Cardiac Myosin Binding Protein-C: Structure, Function, and Regulation
$1,987,279David M Warshaw · University Of Vermont & St Agric College · P01 · FY2014 · HL
SPECIALIZED CENTER OF RESEARCH IN SUDDEN CARDIAC DEATH
$1,985,314Johns Hopkins University · P50 · FY2002 · HL
The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND)
$1,984,101Judith S Hochman · New York University School Of Medicine · R01 · FY2022 · HL
Adaptation to Hypoxia
$1,983,726Kurt R Stenmark · University Of Colorado Denver · P01 · FY2016 · HL
Systematically mapping variant effects for cardiovascular genes
$1,983,411Dan M Roden · Vanderbilt University Medical Center · R01 · FY2024 · HL
RSK3 Anchoring Disruptor Therapy for Heart Failure
$1,982,787Federico Cividini · Cardiac Rsk3 Inhibitors, Llc · R44 · FY2024 · HL
IGF::OT::IGF RD CORONERY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) UMN FI
$1,981,960Pamela Shreiner · Minnesota Univ · N01 · FY2015 · HL
Biology and Therapeutics of Cardiovascular Peptides
$1,981,154Mayo Clinic · P01 · FY2005 · HL
Biology and Therapeutics of Cardiovascular Peptides
$1,979,640John C Burnett · Mayo Clinic Rochester · P01 · FY2007 · HL
Adaptation to Hypoxia
$1,979,638Kurt R Stenmark · University Of Colorado Denver · P01 · FY2017 · HL
Adaptation to Hypoxia
$1,979,638Kurt R Stenmark · University Of Colorado Denver · P01 · FY2019 · HL
The ISCHEMIA Trial - SDCC
$1,979,422Sean M O'Brien · Duke University · U01 · FY2018 · HL
HALF-PINT: Heart and Lung Failure - Pediatric INsulin Titration trial - CCC
$1,979,291Michael Agus · Boston Children'S Hospital · U01 · FY2012 · HL
RSK3 Anchoring Disruptor Therapy for Heart Failure
$1,978,293Federico Cividini · Cardiac Rsk3 Inhibitors, Llc · R44 · FY2023 · HL
Hispanic Community Health Study
$1,976,864Robert Kaplan · Yeshiva University · N01 · FY2011 · HL
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)
$1,976,808Alan Thevenet N. Tita · University Of Alabama At Birmingham · R01 · FY2024 · HL
Genetic insights into cardiovascular function and disease
$1,976,698Paul M Hwang · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Pharmacogenomic Evaluation of Antihypertensive Responses
$1,976,439Julie A. Johnson · University Of Florida · U01 · FY2011 · GM
Protecting Myocardium by Enhancing Mitochodrial Integrity
$1,976,109Mark Alan Sussman · San Diego State University · P01 · FY2009 · HL
Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K) - OVERALL
$1,975,968Santosh Kumar · University Of Memphis · U54 · FY2014 · EB
Mechanisms of cardiac ischemia-reperfusion injury and cardioprotection
$1,975,548Elizabeth Murphy · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL